United Nations NCD Review – Roundtable 2: “Fostering and strengthening national, regional and international partnerships and cooperation in support of efforts to address non-communicable diseases – NCDs” Intervention by Mario Ottiglio, Director, Public Affairs & Global Health Policy, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) New York, 11 July 2014 It is an honor...
Read moreGeneva, 6 June 2014 — Following the campaign’s six-month anniversary, Fight the Fakes is proud to announce eleven new partners, bringing the total number of member organizations to twenty-five. New partners, representing wholesalers, pharmacists, mobile app services, coalitions for consumer protection and generic pharmaceutical manufacturers, join the campaign to speak up and spread the word...
Read moreIFPMA Statement, WHA 67, Item 16.5, Combating antimicrobial resistance, including antibiotic resistance Delivered by Mr Mario Ottiglio, Director, Global Health Policy & Public Affairs, on 24 May 2014 Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across...
Read moreDelivered by Janis Bernat, Associate Director, Biotherapeutics and Scientific Affairs Check against delivery 15.6 Regulatory system strengthening (resolution EB134.R19) Access to biotherapeutic products and ensuring quality, safety and efficacy Thank you for the opportunity to provide input to this important discussion. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents the leading research-based pharmaceutical...
Read moreDelivered by Mario Ottiglio, Director, Public Affairs & Global Health Policy Check against delivery – Item 13.3 Prevention and Control of Non Communicable Diseases NCD Global Coordination Mechanism Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across...
Read moreDelivered by Mario Ottiglio, Director, Public Affairs & Global Health Policy Check against delivery – Item 11.3, Framework of engagement with non-State actors Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world. IFPMA welcomes efforts...
Read moreGeneva, 20 May 2014 – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has published today a new report and recommendations on Hepatitis encouraging a comprehensive approach to fighting this silent epidemic. Titled “Towards a Sustainable, Intersectoral Approach to Viral Hepatitis”, the report is meant to inform the upcoming discussion at the 67th World...
Read moreGeneva, 19 May 2014 – The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called ‘4 Healthy Habits’. This innovative partnership will provide Red Cross and Red Crescent...
Read moreResearch-based pharmaceutical industry adds its voice by calling for greater focus on awareness, research and access. • Psoriasis is a chronic, painful, disfiguring and disabling disease affecting 125 million people worldwide for which there is no cure. • Many go undertreated despite treatments options causing avoidable suffering and high rates of psoriasis associated illnesses; and...
Read moreLatin America Conference Biotherapeutics Medicines — Sharing Experiences and Best Practices Lima, Peru, 19 — 20 November 2013
Read moreBiotherapeutics Medicines — Sharing Experiences and Best Practices Lima, Peru, 19 — 20 November 2013
Read more